Smith & Nephew plc Ordinary USD0.20 (SN.)

Sell : 576.50p | Buy : 577.00p | Market closed 
Prices as at 17:35:49 on 23-07-08

Search UK shares

Lookup



What the Brokers Say

  • Heatbar summary of What the Brokers Say
    Strong
    Sell    		 Strong
    Buy
  • Strong Buy: 7
    Buy: 1
    Neutral: 10
    Sell: 2
    Strong Sell: 2
    Total: 22

This is not a recommendation, it represents the consensus view of a basket of brokers. If less than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.

Important dates

  • Ex-Dividend Date
  • 16-Apr-08
  • Next Results
  • 31-Dec-08
  • Interim Results
  • 7-Aug-08
  • AGM
  • 3-May-07
Place deal now Add to virtual portfolio

Company overview

The Group's core activities are the development and marketing of medical devices in the areas of orthopaedics (joint & hip replacements), endoscopy (equipment to view inside the body – telescope cameras) and advanced wound management. The group operates in 33 countries, employing over 8,000 people and is a leader in each of its three specialist markets.

 

HL Comment (1 May 2008)

The group’s recent first quarter results came in at the lower end of analysts’ expectations, with operating profit rising 12pc to £142m over the quarter and underlying revenues up by 2pc. Furthermore, investors were disappointed by a management discovery regarding poor sales practices at the group’s newly acquired Plus business which is expected to have a highly material impact on sales. Plus is the Swiss company which S&N bought last year for nearly $1 billion. Management noted that the problems were mainly in Greece and forecast a resulting drop in 2008 sales and profits of around $100 million and $25 million, respectively. This combined with what was seen as a cautious management outlook statement saw the shares in retreat following the results announcement. Market consensus opinion is currently favourable in tone, although analysts may now be reassessing their opinions.

All yield figures are variable and not guaranteed.

Fundamental Data

Year Ending Revenue
(m) 		Profit Before Tax
(m) 		EPS
($) 		P/E Ratio PEG EPS Growth
(%)		 Total Dividend Dividend Yield
31-12-2007 3,369.00 469.00 0.34 22.20 0.90 24.00 0.12 1.00
31-12-2006 2,779.00 550.00 0.42 25.30 n/a (1.00) 0.11 1.00
31-12-2005 2,552.00 428.00 0.32 25.20 2.30 11.00 0.08 0.80
31-12-2004 1,249.00 167.00 13.00 27.90 n/a n/a n/a n/a
31-12-2003* 1,178.90 230.10 n/a n/a n/a n/a 4.95 1.10

* Prior to 31st December 2004, figures were stated under UK Generally Accepted Accounting Principles (GAAP). Recent figures stated under International Financial Reporting Standards (IFRS).

Any Overview and Comment is provided by Hargreaves Lansdown. What the Brokers Say, Important Dates and Financials are supplied by Digital Look Ltd. Prices delayed by at least 15 minutes.